皮肤室内辅助器件用于心力衰竭老年患者的皮肤冠状动脉干预:一个向试验仿真
Atsuyuki Watanabe1,2, Yoshihisa Miyamoto3, Hiroki A Ueyama4
1Medicine, Mount Sinai Morningside Hospital, New York, New York, USA.
Heart (British Cardiac Society)
|November 11, 2025
概括
皮肤室内辅助器件 (pVAD) 与大动脉内气球 (IABP) 相比,皮肤室内辅助器件 (pVAD) 在接受皮肤冠状动脉干预 (PCI) 的老年心力衰竭患者中没有显著差异. 死亡率和输血等结果在pVAD和IABP组之间也是相似的.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 医疗保健服务研究 医疗服务研究
背景情况:
- 皮肤穿腹腔辅助装置 (pVAD) 越来越多地用于皮肤穿冠状动脉干预 (PCI) 期间的血液动力支持.
- 患有冠状动脉疾病和心力衰竭 (HF) 的老年患者在开心手术中往往有更高的风险,这使得pVAD成为一个重要的考虑因素.
- 在这个特定的人群中分析pVAD益处对于指导临床决策至关重要.
研究的目的:
- 为了比较患有静心性心力衰竭 (HF) 接受PCI的老年患者的临床结果,pVAD支持的PCI与大动脉内气球 (IABP) 相比.
- 评估这些患者群体中主要不良心血管事件 (MACE) 和住院结果的发生率.
主要方法:
- 针对65至99岁的医疗保险受益者,他们患有缩性高血压,正在接受PCI (2017-2020年) 时,使用了向试验仿真框架.
- 倾向性得分匹配对58个基线共变量进行控制.
- 考克斯回归模型对1年的MACE和其他结果估计了调整后的危险比率 (aHR).
主要成果:
- 在2096名匹配患者中,一年的MACE风险相似:55.4% (pVAD) 与54.7% (IABP),aHR为0.95 (95%CI为0.83-1.10).
- 在pVAD和IABP组之间没有观察到1年死亡率 (aHR0.94) 或术后输血 (调整后风险比1.07) 的显著差异.
- 敏感性分析证实了这些发现.
结论:
- 这项观察性研究没有发现证据表明,与IABP相比,pVAD在接受PCI的患有缩性HF的老年患者中提供了优越的临床结果.
- 根据分析的结果,这些发现表明pVAD和IABP对于这一患者群体的疗效相似.
- 进一步的研究可能是有必要的,以探索针对特定患者配置文件的设备选择中的潜在细微差别.
相关概念视频
Heart Failure VI: Adjunct Therapies
243
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
243
Cardiomyopathy V: Interprofessional Care
323
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
323
Cardiomyopathy II: Dilated Cardiomyopathy
451
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
451
Heart Failure V: Medical Management
207
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
207
Cardiac Catheterization II: Right Heart Catheterization
774
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
774
Heart Failure II: Pathophysiology
695
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
695


